First Patient Treated with Civacir® after Hepatitis C Induced Liver … – PR Newswire (press release)
|
First Patient Treated with Civacir® after Hepatitis C Induced Liver …
PR Newswire (press release) After treatment with virostatics over several weeks, the first patient underwent liver transplantation and subsequently was treated with the Civacir in the Phase III clinical trial. Civacir, a 10 % hepatitis C hyperimmune globulin developed and … Biotest commences phase III trial of hepatitis C therapyZenopa |
